Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
Top Cited Papers
- 1 July 2002
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 360 (9327), 119-129
- https://doi.org/10.1016/s0140-6736(02)09411-4
Abstract
No abstract availableKeywords
Funding Information
- Abbott Laboratories
- Roche
This publication has 46 references indexed in Scilit:
- Bayesian Measures of Model Complexity and FitJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002
- A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA StudyThe Journal of Infectious Diseases, 2002
- Human Immunodeficiency Virus Type 1 RNA Level and CD4 Count as Prognostic Markers and Surrogate End Points: A Meta-AnalysisAIDS Research and Human Retroviruses, 2000
- Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patientsAIDS, 2000
- Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998AIDS, 1999
- The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997AIDS, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- CD4 cell count as a surrogate endpoint in HIV clinical trialsAIDS, 1998
- Differences in Mortality Rates and Causes of Death between HIV Positive and HIV Negative Intravenous Drug UsersInternational Journal of Epidemiology, 1993
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974